影响类弹性蛋白多肽自组装成微球的因素及其作用机制

影响类弹性蛋白多肽(ELPs)自组装成微球的因素较多,目前尚缺乏系统研究。以类弹性蛋白多肽[KV8F]n为对象,利用动态光散射仪测定了不同条件下其自组装成微球的粒径。结果表明:随着分子量的增加ELPs形成的微球粒径也随之增大,粒径的均一度减小;当盐浓度低于0.4 mol/L时,盐浓度的增加,微球粒径相应增加,而盐浓度高于0.4 mol/L则呈减少的趋势,但粒径均大于1.1μm;而当ELPs末端融合木聚糖酶和1,3-丙二醇氧化还原酶后,其自组装形成的微球粒径急剧减小,约为游离ELPs的1/10,分别为151.0 nm和174.2 nm。导致这种现象的原因可能是酶分子和ELPs通过静电引力相互作用后,酶分子的空间位阻妨碍了ELPs分子的聚集。     

超分子多肽自组装在生物医学中的应用

近年来,自组装多肽纳米技术因其可形成规则有序的结构、具有多样的功能而备受关注。研究发现自组装多肽能在特定的条件下形成具有确定结构的聚集体,这种聚集体具备生物相容性好、稳定性高等优点,表现出不同于单体多肽分子的特性和优势,因此其在药物传递、组织工程、抗菌等领域具有良好的应用前景。文中介绍了自组装多肽形成的分子机理、类型、影响因素,综述了自组装多肽形成的纤维肽基水凝胶与自组装抗菌肽的最新进展,并提出目前多肽自组装技术所存在的问题及展望。     

类弹性蛋白多肽及其应用研究进展

类弹性蛋白多肽是一类由VPGXG五肽重复序列串连而成的人工多聚物。其具有在一定温度范围内发生可逆相转变特性,同时具有较好的生物相容性和生物可降解性,使其广泛应用于生物、医学、环境等方面。本文概述类弹性蛋白多肽的相转变特性及其机理,命名分类,并重点阐述其在药物载体、组织工程、免疫测定、影像学等方面的应用。     

温敏类弹性蛋白多肽的基因设计及重组克隆表达

温敏类弹性蛋白多肽(elastin-like polypeptides, ELPs)作为新型的药物载体,在肿瘤治疗中具有广阔的应用前景。本研究根据大肠杆菌密码子的偏好性和简并性,将高度连续重复氨基酸的多种遗传密码引入基因序列中,利用依次插入单体基因和递归定向连接技术,成功构建了以缬氨酸为客座氨基酸的ELPs基因的表达质粒库,即p ET28-ELP-V_5～pET28-ELP-V₅₀。将pET28-V₅₀转化至表达宿主Escherichia coli BL21(DE3)中,经重组菌的培养和IPTG诱导,SDS-PAGE结果显示ELP-V₅₀在大肠杆菌中成功获得了可溶性表达,与预期分子量大小一致。本研究为进一步构建不同分子量的ELPs基因库提供了新的思路,并为重组表达获得特定相变特性的多肽分子奠定了基础。     

自组装在多肽药物中的应用

自组装是指分子、纳米级结构材料等基本单元自发地组装成一个稳定而又紧密结构的过程。多肽可在各种非共价驱动力下自组装形成纳米纤维、纳米层状结构、胶束等不同的形貌。因多肽具有氨基酸序列明确、易于合成、便于设计等优势,多肽自组装技术成为了近年来的一个研究热点。有研究表明,对某些多肽类药物进行自组装设计或者使用自组装肽材料作为药物递送的载体,可以解决药物自身存在的半衰期短、水溶性差、生理屏障穿透率低等问题。本文重点介绍了自组装多肽的形成机制、自组装形貌、影响因素、自组装设计方法及其在生物医学领域的主要应用,为多肽的高效利用提供参考。     

拥挤试剂PEG2000对不同拓扑结构类弹性蛋白相变的影响

类弹性蛋白（Elastin-like polypeptides,ELPs）是属于弹性蛋白中的一种且具有温控性的生物大分子,本文研究拥挤试剂对不同拓扑结构ELPs相变温度的影响,利用温控-紫外分光光度计研究其相变特性,结果发现,随着PEG2000浓度的增加,T-E-F的相变温度下降11.9~17.1℃;在固定Tadpole-like-E浓度下,随着PEG2000浓度的增加,Tadpole-like-E的相变温度降低11.5~16℃,其中,25 μmol/L的Tadpole-like-E其相变速度缓慢;ELPs浓度越大,其相变温度降低愈大,且PEG2000影响ELPs相变温度的趋势与ELPs的拓扑结构关系不大。另外,在简单的PBS缓冲溶液中加入PEG2000,可以使E-C在浓度＜0.5 mol/L的Na2CO3中发生相变,且随着PEG2000浓度的增加,E-C相变温度逐渐降低。本研究为今后ELPs在复杂体系的应用提供前期的基础研究。     

溶剂特性对三臂星型类弹性蛋白多肽相变温度的影响

本文利用SpyTag/SpyCatcher特性构建了三臂星型结构的类弹性蛋白多肽(elastin like polypeptides, ELPs),考察其在不同溶剂,如分子拥挤试剂、osmolytes及深共熔溶剂(deep eutectic solvents,DESs)中的相变温度及行为,并与含有相同ELPs重复数的线性ELPs120作对比。结果表明：在不同浓度拥挤试剂PEG2000作用下,两种结构的ELPs相变温度均降低,当其各自浓度均为25 μmol/L时,三臂星型ELPs相变温度降低3℃～13℃,而ELPs120相变温度仅降低1.5℃～10.8℃。此外,在添加PEG2000后,三臂星型ELPs相变缓慢;在不同类型和浓度的osmolytes溶液中,25 μmol/L三臂星型ELPs相变温度明显要比线性ELPs高8℃左右;在DESs体系中,三臂星型ELPs有类似与水溶液中的相变行为,且其相变温度受到抑制,另外三臂星型ELPs和ELPs120在DESs/PBS体系中,与在(氯化胆碱+尿素)/PBS体系中的相变行为一致,其中当DESs体积含量为50%,ELPs120相变温度是最低的。由于ELPs在非单一缓冲液体系中的相变行为不同,这丰富了ELPs作为纯化标签的应用,且在非单一缓冲液体系中因降低了相变温度,节约了纯化融合蛋白的经济成本,同时也为研究ELPs拓扑结构与其相变行为之间的关系奠定理论基础。     

类弹性蛋白多肽及其在生物医学材料的应用

类弹性蛋白多肽是一种人造基因工程蛋白质聚合物,其结构主要由五肽重复串连序列单元 (GVGXP) 的这一肽段单元重复组成。由于具有可逆相变特征,并可进行高通量生产,加之良好的生物相容性及生物可降解性,使其在新型生物医学材料方面展示了广阔的应用前景。概括了类弹性蛋白多肽的相变机理、合成方法及在生物医学材料上的应用,重点阐述了类弹性蛋白多肽在组织工程、靶向肿瘤、构造药物载体微粒的应用。     

一种溶酶体靶向的原位自组装短肽设计及抗肿瘤活性研究

肿瘤已成为威胁人类生命的一大杀手,目前主要采用手术和放、化疗等手段进行治疗,但由于放、化疗的细胞选择性差、毒副作用明显且易引起肿瘤细胞产生耐受(/药)性,不利于肿瘤的持续治疗,因此亟待研发具有定向定位优势、毒副作用低的新型靶向药物.原位自组装多肽能识别肿瘤部位的特异性高表达物质,在肿瘤部位靶向性聚集形成稳定的纳米结构,实现精准和高效治疗,有望成为一种新型的抗肿瘤药物.本研究基于多肽原位自组装的设计理念,利用溶酶体内组织蛋白酶L的催化活性,设计了靶向溶酶体且能够原位自组装的多肽分子Fmoc-FFRIKFERQ-OH,研究了该分子的自组装特性及抗肿瘤活性.结果显示,在体外酸性条件下,组织蛋白酶L能精准切割Fmoc-FFRIKFERQ-OH分子,其酶切产物FmocFFR-OH自组装形成长纳米纤维结构,对肿瘤细胞A375和SH-SY5Y均具有较好的杀伤作用.该分子通过靶向溶酶体杀伤肿瘤细胞且对正常细胞的毒性较低,有望成为一种新型的抗肿瘤药物.     

自组装无载体纳米药物的研究进展

近年来，自组装无载体纳米药物由于具有高载药量、低毒副作用、合成方法简便等特点，在生物医药领域受到广泛关注，尤其在抗肿瘤和抗菌等方面具有广阔的应用前景和发展潜力。本文简述了无载体纳米药物自组装作用力，详细综述了目前自组装无载体纳米药物的制备方法，着重阐述了其在抗肿瘤、抗菌、抗炎和抗氧化等生物医学领域的应用及研究进展，最后讨论了无载体纳米药物面临的挑战和未来的发展方向，以期为合理设计更有效的自组装无载体纳米药物及其在临床应用提供理论依据。     

Elastin-like Peptide amphiphiles form nanofibers with tunable length

Peptide amphiphiles (PAs) self-assemble nanostructures with potential applications in drug delivery and tissue engineering. Some PAs share environmentally responsive behavior with their peptide components. Here we report a new type of PAs biologically inspired from human tropoelastin. Above a lower critical solution temperature (LCST), elastin-like polypeptides (ELPs) undergo a reversible inverse phase transition. Similar to other PAs, elastin-like PAs (ELPAs) assemble micelles with fiber-like nanostructures. Similar to ELPs, ELPAs have inverse phase transition behavior. Here we demonstrate control over the ELPAs fiber length and cellular uptake. In addition, we observed that both peptide assembly and nanofiber phase separation are accompanied by a distinctive secondary structure attributed primarily to a type-1 β turn. We also demonstrate increased solubility of hydrophobic paclitaxel (PAX) in the presence of ELPAs. Due to their biodegradability, biocompatibility, and environmental responsiveness, elastin-inspired biopolymers are an emerging platform for drug and cell delivery; furthermore, the discovery of ELPAs may provide a new and useful approach to engineer these materials into stimuli-responsive gels and drug carriers.     

Rapid cross-linking of elastin-like polypeptides with (hydroxymethyl)phosphines in aqueous solution

In situ gelation of injectable polypeptide-based materials is attractive for minimally invasive in vivo implantation of biomaterials and tissue engineering scaffolds. We demonstrate that chemically cross-linked elastin-like polypeptide (ELP) hydrogels can be rapidly formed in aqueous solution by reacting lysine-containing ELPs with an organophosphorous cross-linker, beta-[tris(hydroxymethyl)phosphino]propionic acid (THPP) under physiological conditions. The mechanical properties of the cross-linked ELP hydrogels were largely modulated by the molar concentration of lysine residues in the ELP and the pH at which the cross-linking reaction was carried out. Fibroblasts embedded in ELP hydrogels survived the cross-linking process and were viable after in vitro culture for 3 days. DNA quantification of ELP hydrogels with encapsulated fibroblasts indicated that there was no significant difference in DNA content between day 0 and day 3 when ELP hydrogels were formed with an equimolar ratio of THPP and lysine residues of the ELPs. These results suggest that THPP cross-linking may be a biocompatible strategy for the in situ formation of cross-linked hydrogels.     

Tissue scaffolds functionalized with therapeutic elastin-like biopolymer particles

Tissue engineering scaffolds are intended to provide mechanical and biological support for cells to migrate, engraft and ultimately regenerate the tissue. Development of scaffolds with sustained delivery of growth factors and chemokines would enhance the therapeutic benefits, especially in wound healing. In this study, we incorporated our previously designed therapeutic particles, composed of fusion of elastin-like peptides (ELPs) as the drug delivery platform to keratinocyte growth factor (KGF), into a tissue scaffold, alloderm. The results demonstrated that sustained KGF–ELP release was achieved and the bioactivity of the released therapeutic particles was shown via cell proliferation assay, as well as a mouse pouch model in vivo, where higher cellular infiltration and vascularization were observed in scaffolds functionalized with KGF–ELPs.     

In situ cross-linking of elastin-like polypeptide block copolymers for tissue repair

Rapid cross-linking of elastin-like polypeptides (ELPs) with hydroxymethylphosphines (HMPs) in aqueous solution is attractive for minimally invasive in vivo implantation of biomaterials and tissue engineering scaffolds. In order to examine the independent effect of the location and number of reactive sites on the chemical cross-linking kinetics of ELPs and the mechanical properties of the resulting hydrogels, we have designed ELP block copolymers comprised of cross-linkable, hydrophobic ELP blocks with periodic Lys residues (A block) and aliphatic, hydrophilic ELP blocks with no cross-linking sites (B block); three different block architectures, A, ABA, and BABA were synthesized in this study. All ELP block copolymers were rapidly cross-linked with HMPs within several minutes under physiological conditions. The inclusion of the un-cross-linked hydrophilic block, its length relative to the cross-linkable hydrophobic block, and the block copolymer architecture all had a significant effect on swelling ratios of the cross-linked hydrogels, their microstructure, and mechanical properties. Fibroblasts embedded in the ELP hydrogels survived the cross-linking process and remained viable for at least 3 days in vitro when the gels were formed from an equimolar ratio of HMPs and Lys residues of ELPs. DNA quantification of the embedded cells indicated that the cell viability within triblock ELP hydrogels was statistically greater than that in the monoblock gels at day 3. These results suggest that the mechanical properties of ELP hydrogels and the microenvironment that they present to cells can be tuned by the design of the block copolymer architecture.     

Smart tools for antimicrobial peptides expression and application: The elastic perspective

In recent years, antimicrobial peptides (AMPs) have become a promising alternative to the use of conventional and chemically synthesized antibiotics, especially after the emergence of multidrug-resistant organisms. Thus, this review aims to provide an updated overview of the state-of-the-art for producing antimicrobial peptides fused or conjugated with the elastin-like (ELP) peculiar carriers, and that are mostly intended for biomedical application. The elastin-like biopolymers are thermosensitive proteins with unique properties. Due to the flexibility of their modular structure, their features can be tuned and customized to improve the production of the antimicrobial domain while reducing their toxic effects on the host cells. Both fields of research faced a huge rise in interest in the last decade, as witnessed by the increasing number of publications on these topics, and several recombinant fusion proteins made of these two domains have been already described but they still present a limited variability. Herein, the approaches described to recombinantly fuse and chemically conjugate diverse AMPs with ELPs are reviewed, and the nature of the AMPs and the ELPs used, as well as the main features of the expression and production systems are summarized.     

Elastin-like polypeptide based hydroxyapatite bionanocomposites

In nature, organic matrix macromolecules play a critical role in enhancing the mechanical properties of biomineralized composites such as bone and teeth. Designing artificial matrix analogues is promising but challenging because relatively little is known about how natural matrix components function. Therefore, in lieu of using natural components, we created biomimetic matrices using genetically engineered elastin-like polypeptides (ELPs) and then used them to construct mechanically robust ELP-hydroxyapatite (HAP) composites. ELPs were engineered with well-defined backbone charge distributions by periodic incorporation of negative, positive, or neutral side chains or with HAP-binding octaglutamic acid motifs at one or both protein termini. ELPs exhibited sequence-specific capacities to interact with ions, bind HAP, and disperse HAP nanoparticles. HAP-binding ELPs were incorporated into calcium phosphate cements, resulting in materials with improved mechanical strength, injectability, and antiwashout properties. The results demonstrate that rational design of genetically engineered polymers is a powerful system for determining sequence-property relationships and for improving the properties of organic-inorganic composites. Our approach may be used to further develop novel, multifunctional bone cements and expanded to the design of other advanced composites.     

Secretion of elastin-like polypeptides with different transition temperatures by Pichia pastoris

Like natural tropoelastin, polypeptides based on an elastin-like VPGXG repeat have a characteristic inverse temperature response, which leads to coacervate formation above a certain transition temperature and which could be useful for a variety of applications. The key advantage of elastin-like polypeptides (ELPs) over (tropo)elastin is a full control over this temperature response by adjustment of either the amino acid composition or the chain length, according to insights provided by extensive research. Future application of ELPs will require efficient ELP production systems, and in a previous article, we described the successful use of Pichia pastoris for secreted production of an ELP, with an overall yield of ≈ 200 mg L(-1). In this study, we investigated the influence of changed amino acid composition and chain length on the yield of secreted ELP. We have found that both parameters have a distinct impact on the overall yield, with higher yield for shorter and more hydrophilic ELPs. Because yield and transition temperature (Tt) thus appear to be positively correlated, we hypothesize that good solubility of ELP below the Tt promotes the secreted production and coacervate formation above Tt decreases it.     

Non-chromatographic Purification of Recombinant Elastin-like Polypeptides and their Fusions with Peptides and Proteins from Escherichia coli

Elastin-like polypeptides are repetitive biopolymers that exhibit a lower critical solution temperature phase transition behavior, existing as soluble unimers below a characteristic transition temperature and aggregating into micron-scale coacervates above their transition temperature. The design of elastin-like polypeptides at the genetic level permits precise control of their sequence and length, which dictates their thermal properties. Elastin-like polypeptides are used in a variety of applications including biosensing, tissue engineering, and drug delivery, where the transition temperature and biopolymer architecture of the ELP can be tuned for the specific application of interest. Furthermore, the lower critical solution temperature phase transition behavior of elastin-like polypeptides allows their purification by their thermal response, such that their selective coacervation and resolubilization allows the removal of both soluble and insoluble contaminants following expression in Escherichia coli. This approach can be used for the purification of elastin-like polypeptides alone or as a purification tool for peptide or protein fusions where recombinant peptides or proteins genetically appended to elastin-like polypeptide tags can be purified without chromatography. This protocol describes the purification of elastin-like polypeptides and their peptide or protein fusions and discusses basic characterization techniques to assess the thermal behavior of pure elastin-like polypeptide products.     

One-step metal-affinity purification of histidine-tagged proteins by temperature-triggered precipitation

The feature of elastin-like proteins (ELPs) to reversibly precipitate above their transition temperature was exploited as a general method for the purification of histidine (His)-tagged proteins. The principle of the single-step metal-affinity method is based on coordinated ligand-bridging between the modified ELPs and the target proteins. ELPs with repeating sequences of [(VPGVG)(2)(VPGKG)(VPGVG)(2)](21) were synthesized and the free amino groups on the lysine residues were modified by reacting with imidazole-2-carboxyaldehyde to incorporate the metal-binding ligands into the ELP bio- polymers. Biopolymers charged with Ni(2+) were able to interact with a His tag on the target proteins based on metal coordination chemistry. Purifications of two His-tagged enzymes, beta-D-galactosidase and chloramphenicol acetyltransferase, were used to demonstrate the utility of this general method and over 85% recovery was observed in both cases. The bound enzymes were easily released by addition of either EDTA or imidazole. The recovered ELPs were reused four times with no observable decrease in the purification performance.